Heron Therapeutics HRTX Earnings Call Transcripts

NASDAQ HRTX
$0.36 -0.01 (-3.96%)
At close: Nov 11, 2026 · 4:00 PM EST
3 earnings calls on file for Heron Therapeutics, from Q4 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Heron Therapeutics Q2 2026 Earnings Call

Aug 10, 2026 2,732 words · 12 min read
  • Craig CollardChief Executive Officer
  • Ira DuarteExecutive Vice President, Chief Financial Officer
  • Bill ForbesExecutive Vice President, Chief Development Officer
  • Mark HensleyChief Operating Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Heron Therapeutics Earnings Call Transcripts

Calls3
LatestAug 10, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 3 Heron Therapeutics transcripts Register to get access to Heron Therapeutics’s earnings call transcripts.